Preclinical study investigating the potential of low-dose-rate brachytherapy with 32P stents for the prevention of restenosis of paranasal neo-ostia.

Abstract:

PURPOSE:Ostial restenosis is a common cause of failures in paranasal sinus surgery. The aim of the current study was to investigate the use of low-dose-rate brachytherapy to prevent neo-ostial restenosis in an animal model. METHODS AND MATERIALS:In 14 rabbits, maxillary neo-ostia were created and measured. One side each was stented with a regular silicone stent, the other side was either not stented (n = 7) or stented with a phosphorous-32 implanted stent depositing a low-dose radiation of 15 Gy (n = 7) within 1 week, after which all stents were removed. After a period of additional 12 weeks of recovery, the animals were sacrificed, the neo-ostia were again measured, and the areas and histopathologic changes compared in between the groups. RESULTS:After 15-Gy stenting, the mean ostial areas were even slightly enlarged by 5.1% compared to the area at stent removal, whereas a significant reduction in area, indicating a process of restenosis, by 56.1% or 54.0% was seen in the control groups with no stent and normal stent, respectively. Furthermore, no indication for adverse histopathologic radiation effects was seen in the 15-Gy group. CONCLUSIONS:Low-dose-rate brachytherapy with phosphorous-32 doped silicone stents showed promising results in the prevention of neo-ostium restenosis in this proof-of-concept study, indicating that further preclinical and clinical testing may be warranted.

journal_name

Brachytherapy

journal_title

Brachytherapy

authors

Oestreicher E,Bartsch H,Mayr D,Schubert M,Weber B,Kneschaurek P,Assmann W,Sroka R,Betz CS

doi

10.1016/j.brachy.2016.08.011

subject

Has Abstract

pub_date

2017-01-01 00:00:00

pages

207-214

issue

1

eissn

1538-4721

issn

1873-1449

pii

S1538-4721(16)30540-2

journal_volume

16

pub_type

杂志文章
  • Benefit of adaptive CT-based treatment planning in high-dose-rate endorectal brachytherapy for rectal cancer.

    abstract:PURPOSE:In this planning study, we investigated the dosimetric benefit of repeat CT-based treatment planning at each fraction vs. the use of a single CT-based treatment plan for all fractions for high-dose-rate endorectal brachytherapy (HDREBT) for rectal cancer. METHODS AND MATERIALS:We included 11 patients that rece...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2017.08.011

    authors: van den Ende RPJ,Rijkmans EC,Kerkhof EM,Nout RA,Ketelaars M,Laman MS,Marijnen CAM,van der Heide UA

    更新日期:2018-01-01 00:00:00

  • Simulation analysis of optimized brachytherapy for uterine cervical cancer: Can we select the best brachytherapy modality depending on tumor size?

    abstract:PURPOSE:To choose the optimal brachytherapeutic modality for uterine cervical cancer, we performed simulation analysis. METHODS AND MATERIALS:For each high-risk clinical target volume (HR CTV), we compared four modalities [classical conventional intracavitary brachytherapy (ConvICBT), Image-guided ICBT (IGICBT), intra...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2015.10.002

    authors: Yoshida K,Yamazaki H,Kotsuma T,Takenaka T,Ueda MM,Miyake S,Tsujimoto Y,Masui K,Yoshioka Y,Sumida I,Uesugi Y,Shimbo T,Yoshikawa N,Yoshioka H,Tanaka E,Narumi Y

    更新日期:2016-01-01 00:00:00

  • Measuring relief of dysphagia in locally advanced esophageal carcinoma patients submitted to high-dose-rate brachytherapy.

    abstract:BACKGROUND AND PURPOSE:Esophageal neoplasm has a poor prognosis, and palliative care remains an important goal of treatment. The purpose of this study was to assess the ability of high-dose-rate brachytherapy (HDRB) to improve dysphagia in 115 patients treated at our institution. METHODS AND MATERIALS:Patients previou...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2014.09.007

    authors: Grazziotin Reisner R,Reisner ML,Ferreira MA,Rosa AA,Veras IM,Carneiro TM,Wolff B,Viégas CM,Mendonça de Araújo CM,Marchiori E

    更新日期:2015-01-01 00:00:00

  • Radiation oncology and medical physicists quality assurance in British Columbia Cancer Agency Provincial Prostate Brachytherapy Program.

    abstract:PURPOSE:To describe in detail British Columbia (BC) Cancer Agency (BCCA) Provincial Prostate Brachytherapy (PB) Quality Assurance (QA) Program. METHODS AND MATERIALS:The BCCA PB Program was established in 1997. It operates as one system, unified and supported by electronic and information systems, making it a single P...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2012.03.006

    authors: Keyes M,Morris WJ,Spadinger I,Araujo C,Cheung A,Chng N,Crook J,Halperin R,Lapointe V,Miller S,Pai H,Pickles T

    更新日期:2013-07-01 00:00:00

  • Toward four-dimensional image-guided adaptive brachytherapy in locally recurrent endometrial cancer.

    abstract:PURPOSE:To evaluate clinical outcome and feasibility of a four-dimensional image-guided adaptive brachytherapy concept in patients with locally recurrent endometrial cancer. METHODS AND MATERIALS:Forty-three patients with locally recurrent endometrial cancer were included. Treatment consisted of conformal external bea...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2014.06.004

    authors: Fokdal L,Ørtoft G,Hansen ES,Røhl L,Pedersen EM,Tanderup K,Lindegaard JC

    更新日期:2014-11-01 00:00:00

  • A prospective dose escalation trial of high-dose-rate brachytherapy boost for prostate cancer: Evidence of hypofractionation efficacy?

    abstract:PURPOSE:The study aimed to evaluate mature outcomes of a Phase I/II high-dose-rate brachytherapy (HDRB) boost protocol. METHODS AND MATERIALS:We analyzed data from 88 patients with T1a-T3a, N0, M0 prostate adenocarcinoma treated on a prospective Phase I/II HDRB boost protocol of 16 (n = 47) or 20 Gy (n = 41) in four f...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2006.08.007

    authors: Tang JI,Williams SG,Tai KH,Dean J,Duchesne GM

    更新日期:2006-10-01 00:00:00

  • CT-guided permanent 125I seed interstitial brachytherapy for recurrent retroperitoneal lymph node metastases after external beam radiotherapy.

    abstract:PURPOSE:To evaluate the feasibility, efficacy, and safety of permanent (125)I seed interstitial brachytherapy reirradiation in patients with retroperitoneal lymph node recurrence under CT guidance. METHODS AND MATERIALS:Seventeen patients with 19 retroperitoneal lymph node recurrence after external beam radiotherapy u...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2015.05.008

    authors: Yao L,Jiang Y,Jiang P,Wang H,Meng N,Qu A,Tian S,Sun H,Liu C,Wang J,Zhang K

    更新日期:2015-09-01 00:00:00

  • #ThisIsBrachytherapy: Increasing awareness of brachytherapy.

    abstract:PURPOSE:The use of brachytherapy continues to be a vital application of radiation oncology for various cancers. Despite this, there has been a decrease in the utilization of brachytherapy in many cancers. Social media in medicine facilitates engagement and advocacy. We launched a social media campaign to bring awarenes...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2020.07.003

    authors: Kahn JM,Campbell SR,Albert AA,Knoll MA,Shah C

    更新日期:2021-01-01 00:00:00

  • Validation of a radiobiological model for low-dose-rate prostate boost focal therapy treatment planning.

    abstract:PURPOSE:Low-dose-rate brachytherapy using iodine-125 seeds is a highly efficacious treatment for low-risk prostate cancer. We propose a bioeffect model may be used to target an ablative dose to the tumor with a lower, therapeutic dose to low-risk regions to maintain high rates of tumor control with reduced toxicity. We...

    journal_title:Brachytherapy

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.brachy.2013.04.008

    authors: Haworth A,Williams S,Reynolds H,Waterhouse D,Duchesne GM,Bucci J,Joseph D,Bydder S,Ebert M

    更新日期:2013-11-01 00:00:00

  • Comparison of spinal and general anesthesia approaches for MRI-guided brachytherapy for cervical cancer.

    abstract:PURPOSE:To evaluate the impact of general versus spinal anesthesia on postprocedure narcotic use and of extradepartmental planning MRI on treatment time in high-dose-rate brachytherapy for cervical cancer. METHODS AND MATERIALS:Twenty-five patients (10 general anesthesia and 15 spinal anesthesia) who collectively rece...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2018.05.002

    authors: Frankart AJ,Meier T,Minges TL,Kharofa J

    更新日期:2018-01-01 00:00:00

  • Factors impacting all-cause mortality in prostate cancer brachytherapy patients with or without androgen deprivation therapy.

    abstract:PURPOSE:Certain subsets of patients have an increased risk of all-cause mortality when androgen deprivation therapy (ADT) is used with definitive radiotherapy. We evaluated the relationship between pretreatment serum testosterone, age, and comorbidities on survival after prostate brachytherapy in men treated with and w...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2009.06.008

    authors: Taira AV,Merrick GS,Galbreath RW,Butler WM,Wallner KE

    更新日期:2010-01-01 00:00:00

  • LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological models.

    abstract:PURPOSE:Permanent LDR brachytherapy and temporary HDR brachytherapy are competitive techniques for clinically localized prostate radiotherapy. Although a randomized trial will likely never be conducted comparing these two forms of brachytherapy, a comparative radiobiological modeling analysis proves useful in understan...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/S1538-4721(02)00101-0

    authors: King CR

    更新日期:2002-01-01 00:00:00

  • Monte Carlo calculation of the dose perturbations in a dual-source HDR/PDR afterloader treatment unit.

    abstract:PURPOSE:Currently, there are high dose rate afterloaders available that can drive two different radioactive sources simultaneously. The source-source and source-cable attenuations are not taken into account by current planning systems. The purpose of this work is to characterize these effects and their overall impact o...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2016.03.007

    authors: Collins-Fekete CA,Plamondon M,Verhaegen F,Beaulieu L

    更新日期:2016-07-01 00:00:00

  • High-dose-rate brachytherapy as monotherapy for prostate cancer: The impact of cellular repair and source decay.

    abstract:PURPOSE:This work quantifies the influence of intrafraction DNA damage repair and cellular repopulation on biologically effective dose (BED) in Ir-192 high-dose-rate brachytherapy for prostate cancer. In addition, it examines the effect of source-decay-induced BED variation for patients treated at different time points...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2019.04.005

    authors: Tien CJ,Carlson DJ,Nath R,Chen ZJ

    更新日期:2019-01-01 00:00:00

  • Californium-252 neutron brachytherapy combined with external beam radiotherapy for esophageal cancer: long-term treatment results.

    abstract:PURPOSE:The aim of this study was to retrospectively observe and analyze the long-term treatment outcomes for a total of 952 esophageal cancer patients who were treated with (252)Cf neutron brachytherapy (NBT) in combination with external beam radiotherapy (EBRT). METHODS AND MATERIALS:From November 2001 to March 2012...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2014.03.004

    authors: Liu H,Wang Q,Wan X,Jia X,Liu B,Wang CK

    更新日期:2014-09-01 00:00:00

  • Concurrent chemoradiation for cervical cancer: Comparison of LDR and HDR brachytherapy.

    abstract:PURPOSE:To compare clinical outcomes between low-dose-rate (LDR) brachytherapy and high-dose-rate (HDR) brachytherapy for cervical cancer patients. METHODS AND MATERIALS:All consecutive newly diagnosed cervical cancer patients undergoing pretreatment 18-fluorodeoxyglucose positron emission tomography imaging and treat...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2018.11.008

    authors: Lin AJ,Samson P,Zoberi J,Garcia-Ramirez J,Williamson JF,Markovina S,Schwarz J,Grigsby PW

    更新日期:2019-01-01 00:00:00

  • Reirradiation of paraaortic lymph node metastasis by brachytherapy with hyaluronate injection via paravertebral approach: With DVH comparison to IMRT.

    abstract:UNLABELLED:PURPOSE/INTRODUCTION: To safely irradiate retroperitoneal targets as paraaortic lymph node by separating abdominal at-risk organs from the target during irradiation, we created a percutaneous paravertebral approach of high-dose-rate brachytherapy with hyaluronate gel injection (HGI). We report a case treated...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2011.12.004

    authors: Kishi K,Sonomura T,Shirai S,Noda Y,Sato M,Ikushima H,Oh RJ

    更新日期:2013-01-01 00:00:00

  • Validation of the NCCN prostate cancer favorable- and unfavorable-intermediate risk groups among men treated with I-125 low dose rate brachytherapy monotherapy.

    abstract:PURPOSE:To validate the 2019 NCCN subgroups of favorable- and unfavorable-intermediate risk (IR) prostate cancer among patients treated with brachytherapy, who are underrepresented in the studies used to develop the 2019 NCCN classification. METHODS:We included all 2,705 men treated with I-125 LDR brachytherapy monoth...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2019.10.005

    authors: Tom MC,Reddy CA,Smile TD,Zhang RX,Ciezki JP,Stephans KL,Mian OY,Klein EA,Campbell S,Ulchaker J,Angermeier K,Tendulkar RD

    更新日期:2020-01-01 00:00:00

  • In vivo dosimetry in gynecological applications-A feasibility study.

    abstract:PURPOSE:To investigate the feasibility of in vivo dosimetry using microMOSFET dosimeters in patients treated with brachytherapy using two types of gynecological applicators. METHODS AND MATERIALS:In this study, a microMOSFET was placed in an empty needle of an Utrecht Interstitial Fletcher applicator or MUPIT (Martine...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2017.04.240

    authors: Van Gellekom MPR,Canters RAM,Dankers FJWM,Loopstra A,van der Steen-Banasik EM,Haverkort MAD

    更新日期:2018-01-01 00:00:00

  • Dosimetry comparison between TG-43 and Monte Carlo calculations using the Freiburg flap for skin high-dose-rate brachytherapy.

    abstract:PURPOSE:The purpose of this work was to evaluate whether the delivered dose to the skin surface and at the prescription depth when using a Freiburg flap applicator is in agreement with the one predicted by the treatment planning system (TPS) using the TG-43 dose-calculation formalism. METHODS AND MATERIALS:Monte Carlo...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2011.11.005

    authors: Vijande J,Ballester F,Ouhib Z,Granero D,Pujades-Claumarchirant MC,Perez-Calatayud J

    更新日期:2012-11-01 00:00:00

  • Patient-reported health-related quality of life outcomes after HDR brachytherapy between small (

    abstract:PURPOSE:Patients with large prostate glands are underrepresented in clinical trials incorporating brachytherapy due to concerns for excessive toxicity. We sought to compare health-related quality of life (HRQOL) outcomes between small (<60 cc) and large (≥60 cc) prostates treated with high-dose-rate brachytherapy (HDR-...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2018.08.009

    authors: Press RH,Morgan TM,Cutrell PK,Zhang C,Chen Z,Rahnema S,Sanda M,Pattaras J,Patel P,Jani AB,Rossi PJ

    更新日期:2019-01-01 00:00:00

  • The effect of pelvic radiotherapy on vaginal brachytherapy cylinder diameter: Implications for optimal treatment order.

    abstract:PURPOSE:To determine the factors that correlate with cylinder size in vaginal brachytherapy (VB) after hysterectomy for endometrial carcinoma. METHODS AND MATERIALS:Patients treated for endometrial cancer from January 1, 2003 to December 31, 2013 were reviewed from a single institution. Patients included underwent tot...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2016.04.391

    authors: Rakhra SS,Weaver C,Donnelly ED,Helenowski I,Prescott AE,Strauss JB

    更新日期:2016-09-01 00:00:00

  • High-dose-rate interstitial brachytherapy in oral cancer-Its impact on quality of life.

    abstract:PURPOSE:The aim of the study was to assess the impact of high-dose-rate (HDR) interstitial brachytherapy on quality of life (QOL) in oral cancer. METHODS AND MATERIALS:Thirty-two patients of oral cancer treated at our institute from January 2010 to December 2014 with radical radiotherapy (external beam radiotherapy + ...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2016.02.002

    authors: Bajwa HK,Singareddy R,Alluri KR

    更新日期:2016-05-01 00:00:00

  • Needle migration and dosimetric impact in high-dose-rate brachytherapy for prostate cancer evaluated by repeated MRI.

    abstract:PURPOSE:To quantify needle migration and dosimetric impact in high-dose-rate brachytherapy for prostate cancer and propose a threshold for needle migration. METHODS AND MATERIALS:Twenty-four high-risk prostate cancer patients treated with an HDR boost of 2 × 8.5 Gy were included. Patients received an MRI for planning ...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2017.08.005

    authors: Buus S,Lizondo M,Hokland S,Rylander S,Pedersen EM,Tanderup K,Bentzen L

    更新日期:2018-01-01 00:00:00

  • Frequency of whole breast radiation therapy after intraoperative radiation therapy due to criteria identified by lumpectomy.

    abstract:PURPOSE:For selected early breast cancers, intraoperative radiation therapy (IORT) at the time of lumpectomy can be an efficient alternative to fractionated whole breast radiation therapy (WBRT). However, some patients are later recommended WBRT after IORT due to surgical pathologic findings. To understand risk factor ...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2016.09.012

    authors: Mellon EA,Orman A,Joya LE,Montejo ME,Laronga C,Hoover SJ,Lee MC,Khakpour N,Kubal PF,Diaz R

    更新日期:2017-01-01 00:00:00

  • The effect of obesity on rectal dosimetry after permanent prostate brachytherapy.

    abstract:OBJECTIVES:Men with higher body mass index (BMI) tend to have more fatty tissue in prostate-rectum interface, which may reduce the rectal wall dose by the inverse square law. We hypothesized that men with higher BMI will have a lower dose to the rectal wall and less rectal toxicity after permanent prostate implant. ME...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2008.12.001

    authors: Patil N,Crook J,Saibishkumar EP,Aneja M,Borg J,Pond G,Ma C

    更新日期:2009-04-01 00:00:00

  • Locally advanced cervical cancer in renal transplant patients: a dilemma between control and toxicity.

    abstract:PURPOSE:Treatment of locally advanced cervical cancer in patients with a renal graft requires precautions. The graft is usually in a pelvic position, close to the clinical target volume (CTV). Preserving the graft while ensuring local control is a challenge we have faced in two occasions. We report our experience. MET...

    journal_title:Brachytherapy

    pub_type: 社论

    doi:10.1016/j.brachy.2013.11.003

    authors: Maroun P,Rivin E,Dumas I,Mondini M,Brahim J,Haie-Meder C,Mazeron R

    更新日期:2014-01-01 00:00:00

  • Impact of marital status on receipt of brachytherapy and survival outcomes in locally advanced cervical cancer.

    abstract:PURPOSE:Marriage has been associated with enhanced survival among cancer patients, but conflicting correlations have been suggested in cervical cancer. We assessed the impact of marital status on receipt of brachytherapy and survival in women with locally advanced cervical cancer. METHODS AND MATERIALS:Three thousand,...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2019.04.273

    authors: Huynh-Le MP,Klapheke A,Cress R,Mell LK,Yashar CM,Einck JP,Mundt AJ,Mayadev JS

    更新日期:2019-01-01 00:00:00

  • Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecologic cancer: Initial results of a phase II trial.

    abstract:BACKGROUND:This study was undertaken to determine the feasibility of perioperative high-dose-rate brachytherapy (PHDRB) as an adjunct to salvage surgery in primary advanced or recurrent gynecologic cancer. METHODS:Twenty-five patients with either locally advanced (n = 4) or recurrent (n = 21) gynecologic cancer suitab...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2006.07.001

    authors: Martínez-Monge R,Jurado M,Cambeiro M,Valero J,Villafranca E,Alcázar JL

    更新日期:2006-10-01 00:00:00

  • Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.

    abstract:PURPOSE:To evaluate lumpectomy followed by interstitial brachytherapy as an acceptable salvage therapy for women who have developed localized recurrence of breast cancer after conservation surgery and postoperative external radiotherapy. METHODS AND MATERIALS:Between 1/1998 and 10/2006, 21 patients with T0 or T1 in-br...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2007.12.001

    authors: Trombetta M,Julian T,Bhandari T,Werts ED,Miften M,Parda D

    更新日期:2008-01-01 00:00:00